23:28:31 EST Fri 06 Feb 2026
Enter Symbol
or Name
USA
CA



Q:RGEN - REPLIGEN CORP - https://www.repligen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RGEN - Q0.1120.00·145.961.7142.18+2.521.8865.9122,44011,044142.08  145.59  139.80175.57  102.96518:11:43Jan 0615 min RT 2¢

Recent Trades - Last 10 of 11044
Time ETExPriceChangeVolume
18:11:43Q143.734.072
17:43:42Q142.182.528
16:33:26Q141.722.061
16:20:54Q142.472.812
16:20:00Q142.182.52108
16:10:14Q142.182.52279
16:10:04Q142.182.521
16:04:50Q142.182.521
16:04:48Q142.182.521
16:04:23Q142.182.521

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-06 07:30U:RGENNews ReleaseRepligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
2025-12-18 07:30U:RGENNews ReleaseRepligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
2025-12-16 07:30U:RGENNews ReleaseRepligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
2025-11-26 07:30U:RGENNews ReleaseRepligen Corporation to Present at Evercore Healthcare Conference
2025-11-04 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming November Conferences
2025-10-28 07:30U:RGENNews ReleaseRepligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
2025-10-15 07:30U:RGENNews ReleaseRepligen to Report Third Quarter 2025 Financial Results
2025-08-22 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming September Conferences
2025-07-31 07:30U:RGENNews ReleaseRepligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
2025-07-29 07:30U:RGENNews ReleaseRepligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
2025-07-17 07:30U:RGENNews ReleaseRepligen to Report Second Quarter 2025 Financial Results
2025-05-27 07:30U:RGENNews ReleaseRepligen Announces Publication of the Company's 2024 Corporate Sustainability Report
2025-05-22 07:30U:RGENNews ReleaseRepligen Corporation to Present at William Blair Growth Conference
2025-05-07 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming May Investor Conferences
2025-04-29 07:30U:RGENNews ReleaseRepligen Reports First Quarter 2025 Financial Results
2025-04-15 07:30U:RGENNews ReleaseRepligen to Report First Quarter 2025 Financial Results
2025-04-08 07:30U:RGENNews ReleaseRepligen Appoints Jacob Johnson As Vice President Investor Relations
2025-03-04 07:30U:RGENNews ReleaseRepligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
2025-02-20 07:30U:RGENNews ReleaseRepligen Reports Fourth Quarter and Full Year 2024 Financial Results
2025-02-11 07:30U:RGENNews ReleaseRepligen to Report Fourth Quarter and Full Year 2024 Financial Results